microdosing
A new study published in the journal European Psychiatry has shed light on an unconventional approach to managing symptoms associated with Attention-Deficit Hyperactivity Disorder (ADHD). The findings suggest that small, repeated doses of substances like psilocybin and lysergic acid diethylamide (LSD) could potentially help reduce ADHD symptoms and enhance some aspects of emotion regulation. These findings could pave the way for new treatments that focus not only on the primary symptoms of ADHD but also on improving emotional and social functioning. ADHD is typically marked by inattention, hyp...
PsyPost (CA)
A new study published in the journal European Psychiatry has shed light on an unconventional approach to managing symptoms associated with Attention-Deficit Hyperactivity Disorder (ADHD). The findings suggest that small, repeated doses of substances like psilocybin and lysergic acid diethylamide (LSD) could potentially help reduce ADHD symptoms and enhance some aspects of emotion regulation. These findings could pave the way for new treatments that focus not only on the primary symptoms of ADHD but also on improving emotional and social functioning. ADHD is typically marked by inattention, hyp...
PsyPost
A new study published in the journal European Psychiatry has shed light on an unconventional approach to managing symptoms associated with Attention-Deficit Hyperactivity Disorder (ADHD). The findings suggest that small, repeated doses of substances like psilocybin and lysergic acid diethylamide (LSD) could potentially help reduce ADHD symptoms and enhance some aspects of emotion regulation. These findings could pave the way for new treatments that focus not only on the primary symptoms of ADHD but also on improving emotional and social functioning. ADHD is typically marked by inattention, hyp...
PsyPost (UK)
A recent study has shown that even very low doses of LSD can enhance the complexity of brain activity, a finding that might have significant implications for our understanding of consciousness and possibly for therapeutic applications. The study, published in the journal Neuropsychopharmacology, found that while substances like THC (tetrahydrocannabinol) and methamphetamine did not produce the same effect, LSD distinctly increased neural complexity and affected brain wave patterns associated with states of consciousness. Neural complexity is a concept that attempts to quantify the intricate pa...
PsyPost
A recent study has shown that even very low doses of LSD can enhance the complexity of brain activity, a finding that might have significant implications for our understanding of consciousness and possibly for therapeutic applications. The study, published in the journal Neuropsychopharmacology, found that while substances like THC (tetrahydrocannabinol) and methamphetamine did not produce the same effect, LSD distinctly increased neural complexity and affected brain wave patterns associated with states of consciousness. Neural complexity is a concept that attempts to quantify the intricate pa...
PsyPost (CA)
A recent study has shown that even very low doses of LSD can enhance the complexity of brain activity, a finding that might have significant implications for our understanding of consciousness and possibly for therapeutic applications. The study, published in the journal Neuropsychopharmacology, found that while substances like THC (tetrahydrocannabinol) and methamphetamine did not produce the same effect, LSD distinctly increased neural complexity and affected brain wave patterns associated with states of consciousness. Neural complexity is a concept that attempts to quantify the intricate pa...
PsyPost (UK)
Es braucht nicht viel LSD, um das psychische Erleben drastisch zu verändern. So beschreibt es Volker Auwärter. Im Vergleich zu vielen anderen Substanzen gehe es dabei um kleinste Mengen: «Ab 50, 100 Mikrogramm spricht man von einer psychedelischen Dosis», erklärt der Laborleiter der Forensischen Toxikologie am Universitätsklinikum Freiburg. Nicht ohne Grund bezeichnet die zuständige europäische Beobachtungsstelle das verbotene Halluzinogen als eine der «wirkungsstärksten bekannten Drogen überhaupt». Doch was passiert, wenn man die Dosis des Psychedelikums deutlich verringert - auf etwa zehn Mi...
DPA (German)
In a new study from the University of Southern Denmark, researchers have shed light on the effects of microdosing psilocybin, the active component in psychedelic mushrooms, in rats. The study offers preliminary evidence that small, regular doses of psilocybin could potentially offer therapeutic benefits, particularly in reducing stress-induced anhedonia (the inability to feel pleasure) and compulsive behaviors, without inducing significant anxiety or schizophrenic-like symptoms. The findings have been published in Molecular Psychiatry. Psilocybin, long known for its psychedelic effects, has re...
PsyPost
Adults with attention deficit hyperactivity disorder (ADHD) or severe ADHD symptoms who practiced microdosing with psychedelics reported increases in mindfulness after four weeks, according to new preliminary research published in Frontiers in Psychiatry. The findings underscore the importance of conducting future placebo-controlled studies to validate whether these observed changes can be replicated in a controlled experimental environment. ADHD affects millions of adults worldwide, characterized by symptoms like inattention, hyperactivity, and impulsivity. Many individuals with ADHD have tur...
PsyPost
In recent years, the trend of microdosing psychedelics has gained popularity, with enthusiasts touting a wide range of potential benefits, from enhanced creativity to improved mood and focus. However, a recent scientific review published in the Journal of Psychopharmacology has raised concerns about the potential health risks associated with long-term microdosing of psychedelics. In particular, researchers have expressed worry about the possible connection between chronic microdosing and a heart condition known as valvular heart disease (VHD). Microdosing involves taking small, sub-perceptual ...
PsyPost
閲覧を続けるには、ノアドット株式会社が「プライバシーポリシー」に定める「アクセスデータ」を取得することを含む「nor.利用規約」に同意する必要があります。
「これは何?」という方はこちら